Topical Infliximab in Eyes With Penetrating Keratoplasty

NCT05180994 PHASE1, PHASE2 RECRUITING

Penetrating keratoplasty is a cornea surgery involving several inflammatory complications, of which the most important is glaucoma. Researchers wish to determine whether it is safe to administer infliximab (an anti-inflammatory drug) eye drops after surgery, and whether this eye drop could prevent the occurrence of glaucoma.

Details

Lead sponsor	Centre hospitalier de l'Université de Montréal (CHUM)
Phase	PHASE1, PHASE2
Status	RECRUITING
Enrolment	50
Start date	Sun May 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Mar 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Glaucoma Following Surgery

Interventions

• Topical infliximab
• No topical infliximab

Countries

Canada